% | $
Quotes you view appear here for quick access.

Verastem, Inc. (VSTM) Message Board

  • daggidoodle daggidoodle Jun 20, 2013 9:55 AM Flag

    Here's why I'm invested in Verastem

    Verastem (NASDAQ: VSTM) is made up of a team of who’s who scientists, board members, and executives from prestigious universities and Big Pharma companies around. The company is developing a therapeutic approach to use next generation chemotherapeutics to kill cancer stem cells. If the company is successful, a new approach to chemotherapy will be created, one that also attacks cancer recurrence; a large unmet medical need in cancer.

    An investment in Verastem might take a while to appreciate. The company’s most advanced study is VS-6063, which is being used to treat advanced solid tumors. Currently, it is being tested on both mesothelioma and ovarian cancer. According to the company, a regulatory filing could occur as early as early 2015 for this product.

    VS-6063 is just the beginning of the company’s pipeline. It then has VS-4718 to target cancer stem cells and a small molecule inhibitor VS-5584. With the chemotherapy market being $15 billion annually, and there being no form to prevent disease recurrence, it seems likely that Verastem's next generation chemotherapy could be very successful in this large market; although no peak sales have been established.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.84-0.04(-2.13%)Oct 13 4:00 PMEDT